Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization
暂无分享,去创建一个
D. Hafler | J. Bluestone | J. Isaacs | K. Kretschmer | D. Klatzmann | A. ten Brinke | A. Abbas | S. Sánchez-Ramón | H. Waldmann | E. Geissler | M. Battaglia | M. Sykes | M. Roncarolo | M. Levings | I. Joosten | K. Wood | J. Hester | F. Issa | O. Korsgren | C. van Kooten | K. Mills | T. Ritter | C. Piccirillo | P. Witkowski | S. Sakaguchi | B. Blazar | G. Lombardi | B. Sawitzki | A. Putnam | P. Trzonkowski | H. Koenen | M. Vives-Pi | D. Berglund | M. Cuturi | M. Martínez‐Llordella | E. Martínez-Cáceres | E. Jaeckel | M. Bornhäuser | K. Hippen | T. Brusko | N. Giannoukakis | R. Bacchetta | S. Gregori | N. Cools | C. Hilkens | S. M. van Ham | S. Appel | J. Miranda | Q. Tang | D. Miljković | K. Golab | N. Marek-Trzonkowska | A. Fuchs | Mateusz Gliwiński | Nathali Grageda | R. Spiering | N. Ilić | D. Iwaszkiewicz-Grzes | Ljiljana Sofronić-Milosavljević | M. Di Ianni | P. Lord | D. Iwaszkiewicz-Grześ | Anke Fuchs | S. V. van Ham | Karsten Kretschmer
[1] M. Levings,et al. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. , 2016, The Journal of clinical investigation.
[2] Jonathan D. Wren,et al. URL decay in MEDLINE - a 4-year follow-up study , 2008, Bioinform..
[3] Shimon Sakaguchi,et al. The plasticity and stability of regulatory T cells , 2013, Nature Reviews Immunology.
[4] Sylvia Janetzki,et al. "MIATA"-minimal information about T cell assays. , 2009, Immunity.
[5] B. Falini,et al. HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse. , 2014, Blood.
[6] Jeffrey A. Bluestone,et al. Type 1 diabetes immunotherapy using polyclonal regulatory T cells , 2015, Science Translational Medicine.
[7] R. Geffers,et al. Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC‐Specific Chimeric Antigen Receptor , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] A. Piotrowski,et al. Mild hypothermia provides Treg stability , 2017, Scientific Reports.
[9] G. Freeman,et al. CD4+CD25high Regulatory Cells in Human Peripheral Blood1 , 2001, The Journal of Immunology.
[10] S. Hammer,et al. Effect of Ex Vivo–Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques , 2017, Transplantation.
[11] J. Wagner,et al. Adoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[12] J. Myśliwska,et al. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. , 2009, Clinical immunology.
[13] F. Watt,et al. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] H. Volk,et al. Novel GMP‐Compatible Protocol Employing an Allogeneic B Cell Bank for Clonal Expansion of Allospecific Natural Regulatory T Cells , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[15] W. Młynarski,et al. Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes , 2016, Journal of Translational Medicine.
[16] M. Sarwal,et al. Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[17] J. Wagner,et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. , 2011, Blood.
[18] M. Edinger,et al. Regulatory T cells in stem cell transplantation: strategies and first clinical experiences. , 2011, Current opinion in immunology.
[19] B. Falini,et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. , 2011, Blood.
[20] R. Andreesen,et al. Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells , 2004 .
[21] D. Mason,et al. Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro , 2001, European journal of immunology.
[22] M. Toda,et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.
[23] S. Copsel,et al. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[24] A. Lares,et al. Clinical Grade Manufacturing of Human Alloantigen‐Reactive Regulatory T Cells for Use in Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[25] E. d'Hennezel,et al. Coexpression of TIGIT and FCRL3 Identifies Helios+ Human Memory Regulatory T Cells , 2015, The Journal of Immunology.
[26] J. Wagner,et al. Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trials. , 2017, Cytotherapy.
[27] A. Foussat,et al. Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. , 2012, Gastroenterology.
[28] K. Wood,et al. Ex Vivo Expanded Human Regulatory T Cells Can Prolong Survival of a Human Islet Allograft in a Humanized Mouse Model , 2013, Transplantation.
[29] P. Trzonkowski,et al. Cell-Based Therapies with T Regulatory Cells , 2017, BioDrugs.
[30] M. Roncarolo,et al. Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells , 2013, Front. Immunol..
[31] Andrew Bushell,et al. Hurdles in therapy with regulatory T cells , 2015, Science Translational Medicine.
[32] C. Le,et al. Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect. , 2016, Blood.
[33] A. Rudensky,et al. Regulatory T cells: recommendations to simplify the nomenclature , 2013, Nature Immunology.
[34] A. Ribas,et al. Human Antigen-Specific Regulatory T Cells Generated by T Cell Receptor Gene Transfer , 2010, PloS one.
[35] J. Isaacs,et al. Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies , 2016, PeerJ.
[36] E. Bonifacio,et al. Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease. , 2015, Cytotherapy.
[37] P. Witkowski,et al. The Time is Crucial for Ex Vivo Expansion of T Regulatory Cells for Therapy , 2011, Cell transplantation.
[38] E. Bonifacio,et al. T cell receptor repertoires after adoptive transfer of expanded allogeneic regulatory T cells , 2017, Clinical and experimental immunology.
[39] Thomas B Knudsen,et al. MIAME guidelines. , 2005, Reproductive toxicology.